Analysis reportAll specifications met
Retatrutide 30mg
Peptide Stock ref. PSV-2609-RT30-01
Purity99.79%HPLC-UV / ESI-QTOF-MS
Content per vial32.19 mg107.3% of 30 mg label claim
IdentityConfirmedHPLC-UV / ESI-QTOF-MS
Test results
| Test | Specification | Result | Outcome |
|---|---|---|---|
| Identity (HPLC-UV / ESI-QTOF-MS) | Retatrutide | Conforms | Pass |
| Purity (HPLC-UV) | — | 99.79% | Pass |
| Content per vial (LC-MS) | 30 mg label claim | 32.19 mg (107.3% of claim) | Pass |
About this report
- Sample received by the lab 21 September 2026; report issued 25 September 2026.
- 1 vial tested.
- Results relate to the sample tested. For laboratory research use only.